275 related articles for article (PubMed ID: 26778753)
21. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells.
Fan WH; Du FJ; Liu XJ; Chen N
Oncol Rep; 2016 Nov; 36(5):2999-3004. PubMed ID: 27666874
[TBL] [Abstract][Full Text] [Related]
24. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
[TBL] [Abstract][Full Text] [Related]
25. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
26. The TTYH3/MK5 Positive Feedback Loop regulates Tumor Progression via GSK3-β/β-catenin signaling in HCC.
Wang Y; Xie Y; Dong B; Xue W; Chen S; Mitsuo S; Zou H; Feng Y; Ma K; Dong Q; Cao J; Zhu C
Int J Biol Sci; 2022; 18(10):4053-4070. PubMed ID: 35844789
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
28. SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3β/β-catenin signaling in HCC cells.
Liu J; Zhang G; Lv Y; Zhang X; Ying C; Yang S; Kong X; Yu Y
Tumour Biol; 2017 Jun; 39(6):1010428317700408. PubMed ID: 28639896
[TBL] [Abstract][Full Text] [Related]
29. Salt-inducible kinase 2 functions as a tumor suppressor in hepatocellular carcinoma.
Li Y; Yu J; Jia M; Ma P; Dong C
Environ Toxicol; 2021 Dec; 36(12):2530-2540. PubMed ID: 34491613
[TBL] [Abstract][Full Text] [Related]
30. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
31. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
32. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
[TBL] [Abstract][Full Text] [Related]
33. Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling.
Choi HK; Choi KC; Yoo JY; Song M; Ko SJ; Kim CH; Ahn JH; Chun KH; Yook JI; Yoon HG
Mol Cell; 2011 Jul; 43(2):203-16. PubMed ID: 21777810
[TBL] [Abstract][Full Text] [Related]
34. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.
Wei W; Chua MS; Grepper S; So SK
Mol Cancer; 2009 Sep; 8():76. PubMed ID: 19778454
[TBL] [Abstract][Full Text] [Related]
35. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
36. Role of beta-catenin in hepatocarcinogenesis of rats.
Wang QM; Yang KM; Zhou HY; Yu ZH; Li X; Yang HJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):85-9. PubMed ID: 16481290
[TBL] [Abstract][Full Text] [Related]
37. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
[TBL] [Abstract][Full Text] [Related]
38. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
39. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
[TBL] [Abstract][Full Text] [Related]
40. Regulation of β-catenin transcription activity by leupaxin in hepatocellular carcinoma.
Shi J; Wu WJ; Hu G; Yu X; Yu GS; Lu H; Yang ML; Liu B; Wu ZX
Tumour Biol; 2016 Feb; 37(2):2313-20. PubMed ID: 26361959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]